Eligibility and key areas of interest

Ventures working in the following areas will be considered high-priority:
  • Therapeutics: broad range of disease indications (e.g., immunology, oncology, neurology, metabolomics) and categories (e.g., small molecules, biologics, cell and gene therapies).
  • Artificial intelligence/machine learning platforms: supporting drug discovery or digital therapeutics.
  • Enabling platforms: novel drug screen, discovery, and delivery platforms that can result in a novel drug-related IP. 

Ventures must be incorporated in Canada with ambitious growth plans, have at least 1 employee, have proprietary IP, and have raised pre-seed funding.

adMare is committed to equity, diversity, inclusion, and accessibility.


Application process and program duration

Applications for the adMare Tx Accelerator will be accepted on a rolling basis.

Successful applicants will be invited to present in person and undergo due diligence.

Selected ventures will have the opportunity to remain in the program for up to 24 months, based on progress in de-risking therapeutic technologies and achievement of milestones towards entering clinical trials and/or partnerships with pharma, and raising a Series A. 


Submission requirements

All interested Canadian ventures* are invited to apply by submitting a non-confidential proposal summary in pptx or PDF format, covering the following criteria:

  • Problem
  • Technology
  • Supporting Data
  • Intellectual Property
  • Market Size
  • Business and technology development plan
  • Team

*Applications are encouraged from Indigenous people, women, people with disabilities, racialized people and 2SLGBTQIA+ people.



Diligence process and key considerations

Under an NDA, selected ventures will undergo a due diligence process prior to finalization, and are expected to grant access to a data room and must directly provide:

  • Scientific results generated to date 
  • Agreements/contracts in place 
  • IP granted/submitted to date
  • Governance and ownership structure
  • List of all investors and private funding 
  • List of all non-dilutive grants obtained

In case you have any questions regarding the application for the National Tx Accelerator Program, please send an email to the Manager of the National Tx Accelerator, Clara Ducord, at

Submit your application

Please apply to only one of the following accelerator locations:

Québec British-Columbia Ontario

Frequently asked

Yes. However, applications must be submitted by March 1st, 2023, to be included in the first cohort of companies. After the first cohort is selected, applications will be considered on a rolling- basis throughout the year, depending on capacity.

Membership in other commercialization programs or accelerators will be considered on a case by case and in the context of the venture’s plans for technology development and commercialization.

The DD process involves the presentation of the venture’s goals and technology development plan to an internal selection committee under confidentiality. Ventures will also be requested to provide access to data, IP, organizational and business-related materials during the DD process. Each venture should anticipate being in active communication with our team over a two-week period for the DD process.

All Canadian-incorporated companies are invited to apply to the Tx Accelerator. However, we only have wet lab and office spaces available in BC, QC, and ON. Please determine which location is best suited for your company.

Upon acceptance to the Tx Accelerator, each company will enter into an agreement outlining the support that will be provided by the program. Acceptance into the accelerator program does not mean that adMare BioInnovations or its regional partners will automatically provide a direct investment (equity) or continuous funding support for your venture. Direct and in-kind support will be provided to each venture depending on the needs determined at intake.

For more information on the adMare Tx Accelerator and how to apply, watch our webinar.


Get in touch today

Virtual office hours are also available Friday between 2-4pm ET.
For additional information or to schedule an appointment, please contact:

Clara Ducord

Manager, National Accelerator